These findings align with previous research indicating that drug-resistant cancer cells are predisposed to undergo EMT, as evidenced by the observed downregulation of E-cadherin and upregulation of N-cadherin and vimentin in SG-resistant BC cells [46]. The gene discussed is CDH2; the disease is cancer.